B. Riley advisory fee in equity
Company: Core Scientific
The claim, verbatim
Core Scientific agreed to pay B. Riley Securities, Inc. an advisory fee of $750,000 payable in common stock, and issued 386,697 shares of Common Stock on August 1, 2022 in satisfaction of this fee
Source (primary)
Core Scientific 424B3 filed 2022-08-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “In connection with the execution of the Notes, the Company agreed to pay B. Riley Securities, Inc. ("BRS") an advisory fee of $750,000 (the "Advisory Fee") payable in fully paid and non-assessable shares of the Company's common stock... On August 1, 2022, the Company issued 386,697 shares of Common Stock to BRS in satisfaction of the Advisory Fee.”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states Core Scientific agreed to a $750,000 advisory fee to BRS payable in stock and issued 386,697 shares on August 1, 2022 to satisfy it.
Confirmed in the source:
- Core Scientific agreed to pay B. Riley Securities, Inc. an advisory fee of $750,000 payable in common stock
- Core Scientific issued 386,697 shares of common stock on August 1, 2022 in satisfaction of the advisory fee
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522212620/d385020d424b3.htm) in full (13,514 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-08-04
Quote: “In connection with the execution of the Notes, the Company agreed to pay B. Riley Securities, Inc. ("BRS") an advisory fee of $750,000 (the "Advisory Fee") payable in fully paid and non-assessable shares of the Company's common stock... On August 1, 2022, the Company issued 386,697 shares of Common Stock to BRS in satisfaction of the Advisory Fee.”